← Open Payments lookup

MICHAEL SHEEHAN: Open Payments

NPI 1528060597 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,852 in 61 payments from 19 companies in 2025. Trend: 2023 $2,035 · 2024 $1,948 · 2025 $1,852

Food & beverage: $1,852
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$250
Noven Therapeutics, LLC9$214
Indivior Inc.5$199
Neurocrine BioSciences, Inc.3$167
Lundbeck LLC5$165
Teva Pharmaceuticals USA, Inc.3$163
E.R. Squibb & Sons, L.L.C.2$118
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$81
Janssen Pharmaceuticals, Inc3$69
Alkermes, Inc.3$60

Products named: REXULTI, Xelstrym, SUBLOCADE, INGREZZA, AUSTEDO XR, COBENFY, CAPLYTA, SPRAVATO.

Industry payments across FL — which companies pay providers there.